Discover
NVCR
NovoCure Limited
16.69
2 x 12.13
2 x 21.37
bid
ask
-
0.03
0.18%
2 @ 07:30 PM
16.69 +0.00 (0.00%)
| Ytd | 29.08% | |
| 1y | 28.38% |
16.53
day range
16.87
10.03
52 week range
19.99
| Open | 16.70 | Prev Close | 16.72 | Low | 16.53 | High | 16.87 | Mkt Cap | 1.94B |
| Vol | 1.15M | Avg Vol | 1.51M | EPS | -1.30 | P/E | N/A | Forward P/E | -20.44 |
| Beta | 1.01 | Short Ratio | 8.44 | Inst. Own | 90.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 16.74 | 200-d Avg | 14.51 | 1yr Est | 27.14 |
| Income Statement | |||
| Total Revenue | 183.58M | ||
| Revenues (USD) | 183.58M | ||
| Cost of Revenue | 41.11M | ||
| Gross Profit | 142.48M | ||
| Operating Expenses | 153.04M | ||
| Research and Development Expense | 51.45M | ||
| Selling, General and Administrative Expense | 101.59M | ||
| Operating Income | -10.56M | ||
| Interest Expense | 1.89M | ||
| Income Tax Expense | 3.21M | ||
| Net Income | -15.66M | ||
| Net Income Common Stock | -15.66M | ||
| Net Income Common Stock (USD) | -15.66M | ||
| Consolidated Income | -15.66M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -10.56M | ||
| Earning Before Interest & Taxes (USD) | -10.56M | ||
| Weighted Average Shares | 116.01M | ||
| Weighted Average Shares Diluted | 116.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 103.62M | ||
| Cash and Equivalents (USD) | 103.62M | ||
| Investments | 346.86M | ||
| Investments Current | 346.86M | ||
| Trade and Non-Trade Receivables | 145.82M | ||
| Current Assets | 638.52M | ||
| Property, Plant & Equipment Net | 145.74M | ||
| Total Assets | 795.19M | ||
| Total Debt | 233.42M | ||
| Current Liabilities | 220.71M | ||
| Debt Non-Current | 233.42M | ||
| Total Liabilities | 457.10M | ||
| Accumulated Retained Earnings (Deficit) | -1.38B | ||
| Accumulated Other Comprehensive Income | -3.42M | ||
| Shareholders Equity | 338.09M | ||
| Shareholders Equity (USD) | 338.09M | ||
| Assets Non-Current | 156.67M | ||
| Total Debt (USD) | 233.42M | ||
| Inventory | 42.22M | ||
| Liabilities Non-Current | 236.39M | ||
| Trade and Non-Trade Payables | 130.73M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.31M | ||
| Net Cash Flow from Financing | 4.55M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.29M | ||
| Capital Expenditure | -6.92M | ||
| Issuance (Purchase) of Equity Shares | 2.09M | ||
| Net Cash Flow from Investing | -6.38M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 538.00K | ||
| Net Cash Flow from Operations | 8.13M | ||
| Effect of Exchange Rate Changes on Cash | -8.00K | ||
| Share Based Compensation | 17.01M | ||